Spakowicz Lab

EXPLORE THE LAB

Conference abstracts

Conference abstracts are listed separately from our publications.

2026

  1. Sekar N, Zhao S, Rudich A, Johns N, Hwang JD, Su PL, Hu J, Spakowicz D, Wei L, Yang Y, et al. CLO26-084: Prognostic Value of Sarcopenia in Patients With Metastatic NSCLC Receiving First-Line Immune Checkpoint Inhibitors. J Natl Compr Canc Netw. 2026 Mar 31;24. DOI. PubMed.

  2. Hwang JD, Su PL, Zhao S, Hu J, Spakowicz D, Wei L, Baiu I, D’Souza D, Merritt R, Kneuertz P, et al. CLO26-114: Association Between Neoadjuvant Chemoimmunotherapy-Induced Anemia and Survival in Patients With Resectable Non-Small Cell Lung Cancer. J Natl Compr Canc Netw. 2026 Mar 31;24. DOI. PubMed.

2025

  1. Johns N, Rudich A, Zhao S, Chian K, Su PL, Khorasanchi A, Gheeya J, Spakowicz D, Wei L, Roof L, Alahmadi A, Memmott R, Kaufman J, Presley C, He K, Shields P, Rolfo C, Carbone D, Owen D, Li M. CLO25-053: Real-World Evidence of Survival in Patients With Metastatic NSCLC Treated With First-Line Immune Checkpoint Inhibitors Beyond Progression. J Natl Compr Canc Netw. 2025 Mar 28;23(3.5):CLO25-053. DOI. PubMed.

  2. Rudich A, Johns N, Zhao S, Chian K, Su PL, Khorasanchi A, Gheeya J, Spakowicz D, Wei L, Roof L, Alahmadi A, Memmott R, Kaufman J, Presley C, He K, Shields P, Rolfo C, Carbone D, Li M, Owen D. CLO25-080: Outcomes of Extreme Low PD-L1 Expression in Advanced Non-Small Cell Lung Cancer: Implications for Treatment Approaches. J Natl Compr Canc Netw. 2025 Mar 28;23(3.5):CLO25-080. DOI. PubMed.

2022

  1. Quick AM, Pardo DAD, Miller ED, Arnett ALH, Pitter KL, Kim J, Flora L, Williams N, Hoyd R, Wheeler C, Mo X, Chambers L, Spakowicz D, Arthur E. Vaginal Microbiome as a Biomarker of Vaginal Health and Patient-Reported Outcomes in Women Receiving Pelvic Radiation. International Journal of Radiation Oncology, Biology, Physics. Elsevier; 2022 Nov 1;114(3):e462–e463.

2021

  1. Presley C, Mohamed M, Culakova E, Flannery M, Vibhakar P, Spakowicz D, Amini A, VanderWalde N, Wong M, Mohile S. A Geriatric Assessment (GA) intervention to reduce treatment toxicity among older adults with advanced lung cancer: A subgroup analysis from a cluster randomized controlled trial (CRCT). Journal of Geriatric Oncology. Elsevier; 2021;12(8):S54.

2020

  1. Li M, Spakowicz D, Zhao S, et al. Inhaled corticosteroid use and risk of pneumonitis in patients treated with immune checkpoint inhibitors. Journal of Clinical Oncology. 2020;38(15_suppl):3140–3140.